With the Red Sox and Nathan Eovaldi officially in agreement on a four-year, $68-million deal Thursday, here are some thoughts on the signing and its impact.
1.Risk? Of course. But worth it.
Some have questioned the wisdom of giving such a contract to a pitcher who has undergone two Tommy John surgeries and has only pitched more than 155 innings once in his seven-year major league career.
But every major league pitcher carries with him some degree of risk. Rare is the pitcher who is without physical issues at some point in his career. And there's some body of evidence which suggests that having already undergone two surgeries on his elbow, Eovaldi actually stands a better chance of maintaining his health.
As for his lack of track record, some of that, naturally, is related to his physical issues. He missed all of 2017 and parts of 2016 and 2018 because of the second Tommy John surgery.